Equities

Envoy Medical Inc

COCH:NAQ

Envoy Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.21
  • Today's Change0.020 / 0.63%
  • Shares traded3.06k
  • 1 Year change-69.25%
  • Beta2.3205
Data delayed at least 15 minutes, as of Sep 20 2024 17:40 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

  • Revenue in USD (TTM)302.00k
  • Net income in USD-16.27m
  • Incorporated2020
  • Employees34.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
LENSAR Inc45.12m-12.56m50.03m130.00--2.10--1.11-1.11-1.113.923.240.68061.259.08347,107.70-18.94-30.97-22.49-36.9449.8751.04-27.83-52.302.15--0.00--19.2511.5727.77---42.91--
Adagio Medical Holdings Inc0.00-2.54m54.35m----1.36-----0.1856-0.18560.002.990.00-------6.73---9.12--------------0.1226-------299.85------
Heartbeam Inc0.00-16.91m56.31m15.00--6.47-----0.6375-0.63750.000.32780.00----0.00-106.50---113.62--------------0.00-------12.94------
Medinotec Inc6.93m-339.77k58.67m35.00------8.46-0.029-0.0290.59070.19181.545.3623.11198,040.90-7.54---8.32--44.05---4.90--3.863.970.3601--402.25---14.73------
Pheton Holdings Ltd628.59k-241.22k60.56m11.00--166.52--96.35-0.0201-0.02010.05240.0255------57,144.55--------74.90---38.37--0.3984--0.00---7.53---387.24------
Nutriband Inc1.80m-7.24m62.14m13.00--4.99--34.45-0.8122-0.81220.19841.120.15356.2912.38---61.64-55.21-67.30-66.7433.6233.32-401.62-315.876.36--0.0156--0.274153.43-22.35--65.57--
Envoy Medical Inc302.00k-16.27m62.52m34.00------207.03-0.7683-0.76830.0172-0.6320.06470.56862.648,882.35-290.14-------171.85---4,481.79--0.4237-38.98----33.33---87.83------
Work Medical Technology Group Ltd13.57m112.03k64.79m216.00575.136.5239.884.780.00770.00770.93560.68110.48892.104.1062,805.320.2284--0.6332--30.54--0.4673--0.92651.120.4459---31.18---87.05------
Alpha Pro Tech, Ltd.61.09m4.71m64.92m124.0014.151.0411.461.060.41060.41065.325.580.89171.737.25492,653.206.8815.217.0716.0639.2940.237.7112.9317.19--0.000.00-1.215.6027.642.935.50--
TELA Bio Inc64.74m-42.11m66.23m227.00--23.04--1.02-1.71-1.712.640.11630.83761.487.62285,215.80-54.48-52.00-66.54-60.9568.6165.32-65.04-107.652.52-8.690.9343--41.1347.85-5.35---17.12--
Vivos Inc25.00k-2.81m66.75m10.00--41.72--2,669.91-0.0075-0.00750.000070.00380.014--2.56---157.67-202.25-171.09-552.77-3.1210.79-11,223.64-11,969.07----0.00---46.58---17.19------
InspireMD Inc6.57m-25.52m66.99m65.00--1.40--10.20-0.7389-0.73890.19071.860.12022.574.73101,030.80-46.71-60.59-52.36-72.9723.8520.46-388.67-334.787.13--0.00--20.0011.50-7.71--41.57--
Owlet Inc65.64m-15.92m67.98m76.00------1.04-1.89-1.897.61-2.291.273.484.39863,618.40-20.24---165.32--45.71---15.91--0.8168-40.50-----21.95--52.74------
Milestone Scientific Inc8.42m-4.62m70.59m17.00--8.86--8.38-0.0614-0.06140.10960.1030.72740.576314.32495,440.60-40.16-55.48-56.48-74.7272.4463.97-55.21-88.941.81--0.0007--11.600.423320.41---7.99--
Modular Medical Inc0.00-17.87m73.59m39.00--9.18-----0.6986-0.69860.000.24620.00----0.00-150.56-187.51-167.12-234.72------------0.00-------25.87--85.63--
Hyperfine Inc11.94m-41.45m75.53m131.00--1.12--6.32-0.5773-0.57730.16630.92480.12620.98562.5691,160.30-43.81---48.08--44.51---347.05--7.24--0.00--61.90--39.54------
Data as of Sep 20 2024. Currency figures normalised to Envoy Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

2.94%Per cent of shares held by top holders
HolderShares% Held
Hightower Advisors LLCas of 30 Jun 2024164.32k0.84%
The Vanguard Group, Inc.as of 30 Jun 2024112.14k0.57%
Geode Capital Management LLCas of 30 Jun 202486.96k0.44%
Polar Asset Management Partners, Inc.as of 30 Jun 202480.00k0.41%
Corient Private Wealth LLCas of 30 Jun 202438.16k0.20%
Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 202431.54k0.16%
SSgA Funds Management, Inc.as of 30 Jun 202423.87k0.12%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 202414.04k0.07%
JPMorgan Alternative Asset Management, Inc.as of 31 Dec 202212.35k0.06%
Marquette Asset Management LLCas of 30 Jun 202411.72k0.06%
More ▼
Data from 31 Dec 2022 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.